PFM Health Sciences as of Sept. 30, 2024
Portfolio Holdings for PFM Health Sciences
PFM Health Sciences holds 74 positions in its portfolio as reported in the September 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Eli Lilly & Co. (LLY) | 15.0 | $265M | 299k | 885.94 | |
Tenet Healthcare Corp Com New (THC) | 5.6 | $98M | 589k | 166.20 | |
Cytokinetics Com New (CYTK) | 5.3 | $93M | 1.8M | 52.80 | |
Abbvie (ABBV) | 4.5 | $80M | 404k | 197.48 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.9 | $69M | 149k | 465.08 | |
Intuitive Surgical Com New (ISRG) | 3.8 | $68M | 137k | 491.27 | |
Merck & Co (MRK) | 3.5 | $62M | 543k | 113.56 | |
Hca Holdings (HCA) | 2.9 | $51M | 125k | 406.43 | |
Universal Hlth Svcs CL B (UHS) | 2.8 | $49M | 214k | 229.01 | |
McKesson Corporation (MCK) | 2.7 | $48M | 98k | 494.42 | |
Argenx Se Sponsored Adr (ARGX) | 2.7 | $47M | 87k | 542.08 | |
UnitedHealth (UNH) | 2.5 | $44M | 76k | 584.68 | |
Acadia Healthcare (ACHC) | 2.5 | $44M | 686k | 63.41 | |
Axsome Therapeutics (AXSM) | 2.4 | $42M | 467k | 89.87 | |
Thermo Fisher Scientific (TMO) | 2.0 | $36M | 58k | 618.57 | |
Danaher Corporation (DHR) | 2.0 | $35M | 126k | 278.02 | |
Spdr Ser Tr S&p Biotech Call Option (XBI) | 1.9 | $34M | 340k | 98.80 | |
Icon SHS (ICLR) | 1.9 | $34M | 117k | 287.31 | |
Penumbra (PEN) | 1.8 | $32M | 166k | 194.31 | |
Humana (HUM) | 1.8 | $32M | 102k | 316.74 | |
Anthem (ELV) | 1.7 | $29M | 56k | 520.00 | |
Amgen (AMGN) | 1.6 | $29M | 90k | 322.21 | |
Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 1.5 | $27M | 23M | 1.17 | |
Iqvia Holdings (IQV) | 1.5 | $27M | 112k | 236.97 | |
Edwards Lifesciences (EW) | 1.5 | $26M | 391k | 65.99 | |
Becton, Dickinson and (BDX) | 1.4 | $25M | 102k | 241.10 | |
Stryker Corporation (SYK) | 1.4 | $24M | 67k | 361.26 | |
Molina Healthcare (MOH) | 1.4 | $24M | 70k | 344.56 | |
Inspire Med Sys (INSP) | 1.2 | $21M | 98k | 211.05 | |
Waters Corporation (WAT) | 1.0 | $18M | 51k | 359.89 | |
Oscar Health Cl A (OSCR) | 1.0 | $18M | 861k | 21.21 | |
Essa Pharma Com New (EPIX) | 0.9 | $17M | 2.7M | 6.06 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $14M | 91k | 149.31 | |
Erasca (ERAS) | 0.8 | $13M | 4.9M | 2.73 | |
Insmed Com Par $.01 (INSM) | 0.6 | $11M | 152k | 73.00 | |
Sarepta Therapeutics (SRPT) | 0.6 | $11M | 88k | 124.89 | |
Celcuity (CELC) | 0.6 | $11M | 710k | 14.91 | |
Praxis Precision Medicines I Com New (PRAX) | 0.6 | $11M | 183k | 57.54 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.5 | $9.5M | 10M | 0.95 | |
Boston Scientific Corporation (BSX) | 0.5 | $9.1M | 109k | 83.80 | |
Sarepta Therapeutics Note 1.250% 9/1 (Principal) | 0.5 | $8.8M | 7.8M | 1.14 | |
Caribou Biosciences (CRBU) | 0.5 | $8.4M | 4.3M | 1.96 | |
Syndax Pharmaceuticals (SNDX) | 0.5 | $8.2M | 424k | 19.25 | |
Werewolf Therapeutics (HOWL) | 0.4 | $7.2M | 3.4M | 2.12 | |
Xenon Pharmaceuticals (XENE) | 0.4 | $7.1M | 180k | 39.37 | |
Concentra Group Holdings Par Common Stock (CON) | 0.4 | $6.7M | 300k | 22.36 | |
Keros Therapeutics (KROS) | 0.3 | $5.9M | 101k | 58.07 | |
Alkermes SHS (ALKS) | 0.3 | $5.7M | 205k | 27.99 | |
Intra Cellular Therapies (ITCI) | 0.3 | $5.7M | 77k | 73.17 | |
Tg Therapeutics (TGTX) | 0.3 | $5.5M | 233k | 23.39 | |
Arcellx Common Stock (ACLX) | 0.3 | $5.1M | 61k | 83.51 | |
Day One Biopharmaceuticals I (DAWN) | 0.3 | $4.8M | 342k | 13.93 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.2 | $4.3M | 269k | 15.99 | |
Veeva Sys Cl A Com (VEEV) | 0.2 | $4.0M | 19k | 209.87 | |
Longboard Pharmaceuticals In | 0.2 | $3.8M | 114k | 33.33 | |
Ocular Therapeutix (OCUL) | 0.2 | $3.5M | 403k | 8.70 | |
Immunovant (IMVT) | 0.2 | $3.5M | 123k | 28.51 | |
Cullinan Oncology (CGEM) | 0.2 | $3.1M | 183k | 16.74 | |
Pulmonx Corp (LUNG) | 0.2 | $3.1M | 369k | 8.29 | |
Pmv Pharmaceuticals (PMVP) | 0.2 | $3.0M | 2.0M | 1.49 | |
Compass Pathways Sponsored Ads (CMPS) | 0.2 | $2.8M | 451k | 6.30 | |
Io Biotech (IOBT) | 0.1 | $2.5M | 2.3M | 1.05 | |
Capricor Therapeutics Com New (CAPR) | 0.1 | $2.3M | 153k | 15.21 | |
Metagenomi (MGX) | 0.1 | $2.2M | 1.0M | 2.17 | |
Ark Etf Tr Genomic Rev Etf (ARKG) | 0.1 | $2.2M | 87k | 25.60 | |
Inhibrx Biosciences (INBX) | 0.1 | $2.1M | 136k | 15.66 | |
Generation Bio (GBIO) | 0.1 | $1.9M | 788k | 2.47 | |
Sagimet Biosciences Com Ser A (SGMT) | 0.1 | $1.8M | 649k | 2.77 | |
Celldex Therapeutics Com New (CLDX) | 0.1 | $1.8M | 52k | 33.99 | |
Iovance Biotherapeutics (IOVA) | 0.1 | $1.2M | 132k | 9.39 | |
Boundless Bio (BOLD) | 0.0 | $835k | 241k | 3.47 | |
Verve Therapeutics (VERV) | 0.0 | $610k | 126k | 4.84 | |
Uniqure Nv SHS (QURE) | 0.0 | $600k | 122k | 4.93 | |
Turnstone Biologics Corp (TSBX) | 0.0 | $519k | 932k | 0.56 |